- Donald Trump is currently re-evaluating the federal classification of marijuana, indicating a decision could be made in the coming weeks.
- A potential reclassification from a Schedule I to a Schedule III drug would not lead to nationwide recreational legalisation but would alter regulation, taxation, and facilitate research.
- This change could result in significant tax savings for legal marijuana businesses, though it is not expected to resolve banking sector reluctance.
- Trump describes the issue as "very complicated," weighing perceived medical benefits against other concerns, while facing opposition from some conservative and law enforcement groups.
- The re-evaluation occurs amidst widespread state-level legalisation of medical and recreational marijuana, and growing public support for legalisation across the United States.
IN FULL